Provided by Tiger Trade Technology Pte. Ltd.

Fate Therapeutics

1.15
+0.04003.60%
Post-market: 1.160.0100+0.87%19:34 EST
Volume:1.41M
Turnover:1.59M
Market Cap:132.66M
PE:-0.87
High:1.17
Open:1.12
Low:1.09
Close:1.11
52wk High:2.07
52wk Low:0.6611
Shares:115.35M
Float Shares:100.80M
Volume Ratio:1.32
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3180
EPS(LYR):-1.6384
ROE:-52.35%
ROA:-23.85%
PB:0.57
PE(LYR):-0.70

Loading ...

Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2025

Major Issues Report

Form 8-K - Current report
Oct 21, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities